Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 501.45 +9.19 (+1.87%) Streaming Delayed Price Updated: 12:44 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 50 51 Next > 3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April April 09, 2024 These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term. Via InvestorPlace Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. April 09, 2024 These companies are close to launching new products that could supercharge revenue. Via The Motley Fool Got $1,000? 2 Bulletproof Stocks to Buy in 2024 and Hold for the Long Haul April 05, 2024 These businesses are booming. Via The Motley Fool Biotech Sector Nears Breakout: Will it Outperform in Q2? April 03, 2024 The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains Via MarketBeat Topics ETFs Missed the "Magnificent Seven"? Try Buying These 3 Forever Stocks Instead April 01, 2024 All three companies have very long runways for growth ahead. Via The Motley Fool 1 Top Growth Stock to Buy and Hold Forever March 31, 2024 This drugmaker looks unstoppable. Via The Motley Fool If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,400 Today March 25, 2024 Via Benzinga Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease April 01, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire Meet The "Magnificent Seven" of Healthcare Stocks April 01, 2024 The tech sector doesn't have a monopoly on magnificent corporations. Via The Motley Fool 2 Rock-Solid Growth Stocks to Buy Right Now and Hold for at Least 5 Years March 31, 2024 Great businesses are here to stay. These are two excellent examples. Via The Motley Fool 3 Unstoppable Stocks to Buy Hand Over Fist in April March 30, 2024 These stocks have exceptionally bright prospects. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session March 28, 2024 Via Benzinga Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why March 28, 2024 The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia. Via Investor's Business Daily 3 Biotech Stocks to Buy for the Next Bull Run: March 2024 March 26, 2024 These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run. Via InvestorPlace Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich March 25, 2024 Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. Via InvestorPlace FDA Approves Vertex Pharmaceuticals (NASDAQ:VRTX) VX-407 for Phase I Study in Groundbreaking Move Against Polycystic Kidney Disease” March 25, 2024 Via AB Newswire Exposures Product Safety Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) March 21, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire 3 Biopharma Stocks Predicted to Soar in Q2 2024 March 20, 2024 These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals. Via InvestorPlace Geron Stock Doubles After Imetelstat Receives FDA Panel Approval March 20, 2024 Geron stock is up more than 92% after the company's flagship blood cancer therapy received approval from an FDA advisory panel Via MarketBeat Exposures Product Safety From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires March 19, 2024 These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations. Via InvestorPlace 2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now March 17, 2024 It's always a good time to buy great stocks with excellent prospects. Via The Motley Fool 3 Unstoppable Stocks You Can Buy Now Without Any Hesitation March 17, 2024 There's no need for delays in buying these great stocks. Via The Motley Fool Forget Tesla, Buy This Magnificent Healthcare Stock Instead March 17, 2024 Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future. Via The Motley Fool Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon. March 09, 2024 Good news could be in store for all three of these drugmakers. Via The Motley Fool Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years March 08, 2024 Via Benzinga The Top 3 Biotech Stocks to Buy in March 2024 March 06, 2024 Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors. Via InvestorPlace 3 Biopharma Stocks You Don't Want to Miss in the New Bull Market March 05, 2024 All three have exciting programs on the way. Via The Motley Fool Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making March 05, 2024 These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward. Via InvestorPlace Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits March 04, 2024 Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising. Via InvestorPlace ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential March 04, 2024 Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence < Previous 1 2 3 4 5 6 7 8 9 ... 50 51 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.